Sachdev is an early career researcher in the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health. She received her undergraduate degree in Biotechnology from KIIT University in India.

oncology research led me to pursue a BSc in Biology & Economics from Carleton University, and an MSc in Biotechnology In my role at Orion Biotechnology, I work at the intersection of science and business, which includes Caron currently holds multiple scientific advisory roles in academia, industry and the National Institutes Undergraduate Research Program and is working to build relationships with key stakeholders through institutional

Ralf Jockers Ralf Jockers studied in Cologne and received a Ph.D. in biotechnology and biochemistry from His laboratory is currently located at the Institute Cochin – Inserm (Paris, France).

Deputy Director, and Better Medicines Theme Leader of the Neuromedicines Discovery Centre at the Monash Institute Prior to these roles this he was Head of Pharmacology at Heptares Therapeutics Ltd., a UK-based biotechnology

University of Montreal in Canada before training at Rockefeller University in New York and the National Institutes Sachdev is an early career researcher in the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health. She received her undergraduate degree in Biotechnology from KIIT University in India. GPCR About Cam Sinh Lu Cam Sinh Lu is a PhD student at Monash Institute of Pharmaceutical Sciences, Monash

Elodie Dupuis earned her Master’s degree in biology and biotechnology engineering from the University She has been leading collaborative projects with public research institutes and pharmaceutical companies , most notably the joint Revvity/Institute of Functional Genomics team, EIDOS. Mathis holds a biotechnology engineering degree from the National School of Biomolecule Technology of

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes Caroline Gorvin is a Wellcome Trust & Royal Society Sir Henry Dale Fellow at the Institute of Metabolism

Arun Shukla's lab at the Indian Institute of Technology, Kanpur attacks this question from multiple angles He completed his PhD at the Max Planck Institute of Biophysics in Frankfurt and postdoctoral training Arun Shukla from the Indian Institute of Technology in Kanpur, India. He earned his master's degree in biotechnology from Jawaharlal Nehru University in India and it was during Arun Shukla on the web Indian Institute of Technology Dr.

competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology Additionally, they explored the unique culture and structure of their Institute, highlighting its translational Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, research, highlighting the unique opportunities presented by their location and partnerships with other institutions

competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology Additionally, they explored the unique culture and structure of their Institute, highlighting its translational Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, research, highlighting the unique opportunities presented by their location and partnerships with other institutions

Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . Oliver Hartley on the web LinkedIn Orion Biotechnology Dr. GPCR Ecosystem Unlock the Full Dr.

Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in During his master's studies, he specialized in Biomedical Biotechnology and Structural Biology/Biochemistry

following three years on the editorial teams of Nature Structural and Molecular Biology and Nature Biotechnology

Last summer, Julia worked at as the first-ever summer intern at Septerna, the GPCR-based biotechnology

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes

Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics Ltd , a biotechnology

Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr.

in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology group of Martin Lohse at the Institute order to focus my research on class Frizzled GPCR s in the lab of Gunnar Schulte at the Karolinska Institute Hannes Schihada on the web Karolinska Institutet Twitter Adher´n Rise LinkedIn Dr.

based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology

Gunnar Schulte of Karolinska Institute makes the case that frizzled receptors are GPCRs — through G-protein Gunnar Schulte's lab at Karolinska Institute has spent years assembling the evidence on the other side Guest Gunnar Schulte is a professor at the Department of Physiology and Pharmacology at Karolinska Institute pivoted to frizzled receptors during a postdoctoral fellowship with Ernest Arenas, staying at the same institution As a postdoc, he trained first with Ernest Arenas (Karolinska Institutet, Molecular Neurobiology; 2003

Avanzados del IPN (in English: Center for Research and Advanced Studies of the National Polytechnic Institute Instituto Politécnico Nacional no 2508 Mexico City, C.P. 07360 Room: Auditorium Arturo Rosenblueth *Have

His scientific training included a PhD at the International Center for Genetic Engineering and Biotechnology

Trained initially as a biotechnology engineer, Jens discovered his true calling during an internship

where everything he has cared about — biochemistry, cell communication, disease, and the students other institutions a research field in an underrepresented scientific ecosystem, and recruiting from communities elite institutions In this institution dear to the heart of GPCR enthusiasts given that its faculty personnel included Dr integrating the department of Cell Biology at the Centro de Investigación y de Estudios Avanzados del Instituto He also actively volunteers as an Associate Professor of the non-governmental organization Institut des

competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology

of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery and development biotechnology

She has worked across pharmaceutical, biotechnology, and academic settings, including a research placement

Kathryn E Livingston is currently a Product Manager at Gator Bio , a biotechnology company providing

He is also an entrepreneur and founder of biotechnology companies translating GPCR pharmacology into

Gainetdinov is the Institute of Translational Biomedicine Director at Saint Petersburg State University Gainetdinov was a Senior Researcher in the Department of Neuroscience and Brain Technologies at the Italian Institute From 2013-2018, he was also a Professor at the Skolkovo Institute of Science and Technology (Skoltech Department of Cell Biology in 1996 as a postdoc and becoming faculty at Duke in 2000, he researched at the Institute 1992 from the Russian Academy of Medical Sciences and an M.D. in 1988 from the Second Moscow Medical Institute